Investor contact
Get in touch with investor relations.
We welcome inquiries from shareholders, prospective investors, financial institutions and others in the investment community.
NÖK Therapeutics, Inc.
- Investor relations
- pdeschamps@noktx.com
- Corporate headquarters
- 2009 Mackenzie Way, Suite 100Cranberry Township, PA 16066United States
- Telephone
- 614-596-2597
Shareholder services
For registered share ownership, transfers or other securities administration, please contact our transfer agent.
- Transfer agent
- ClearTrust, LLC
- Phone
- 813.235.4490
- Fax
- 813.388.4549
- Email (general)
- inbox@cleartrusttransfer.com
- Email (ClearConnect)
- support@cleartrusttransfer.com
- Website
- cleartrustonline.com
Please noteNÖK Therapeutics does not give individual investment advice or recommendations about buying or selling its securities. We can't respond to requests for material non-public information, unpublished financial results, stock price projections or other confidential information. Please refer to our public disclosures for current information.
Investing in biotechnology companies involves substantial risks, including risks associated with research and development, regulatory approval, financing and commercialization. Investors should review the company'sSEC filings and the risk disclosures in them before making investment decisions. Nothing on this website is an offer to sell, or a solicitation of an offer to buy, any securities, or investment advice. See our legal disclosures and forward-looking statements.